KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Other Accumulated Expenses (2020 - 2025)

LifeMD (LFMD) has disclosed Other Accumulated Expenses for 6 consecutive years, with $1.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Accumulated Expenses fell 38.03% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Dec 2025, down 38.03%, and an annual FY2025 reading of $1.0 million, down 38.03% over the prior year.
  • Other Accumulated Expenses was $1.0 million for Q4 2025 at LifeMD, down from $2.3 million in the prior quarter.
  • Across five years, Other Accumulated Expenses topped out at $3.4 million in Q3 2024 and bottomed at $1.0 million in Q4 2025.
  • Average Other Accumulated Expenses over 5 years is $2.0 million, with a median of $1.9 million recorded in 2022.
  • The sharpest move saw Other Accumulated Expenses soared 88.96% in 2021, then tumbled 38.03% in 2025.
  • Year by year, Other Accumulated Expenses stood at $2.1 million in 2021, then dropped by 9.24% to $1.9 million in 2022, then dropped by 3.94% to $1.8 million in 2023, then decreased by 10.27% to $1.6 million in 2024, then crashed by 38.03% to $1.0 million in 2025.
  • Business Quant data shows Other Accumulated Expenses for LFMD at $1.0 million in Q4 2025, $2.3 million in Q3 2025, and $1.8 million in Q2 2025.